drugset / Trial / NCT07040566

A Trial of Varenicline for E-cigarette Cessation

NCT07040566

RandomizedParallel-groupDouble-blindTreatment

Summary

This is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.

Timeline

Start
2025-10-14
Primary completion
2030-07-30
Completion
2030-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg

Indications